Volgen
Habip Gedik
Habip Gedik
University of Health Sciences Bakırköy Sadi Konuk Research Hospital
Geverifieerd e-mailadres voor beah.gov.tr
Titel
Geciteerd door
Geciteerd door
Jaar
Polymyxin monotherapy or in combination against carbapenem-resistant bacteria: systematic review and meta-analysis
O Zusman, S Altunin, F Koppel, Y Dishon Benattar, H Gedik, M Paul
Journal of Antimicrobial Chemotherapy 72 (1), 29-39, 2016
1762016
Money and transmission of bacteria
H Gedik, TA Voss, A Voss
Antimicrobial resistance and infection control 2, 1-4, 2013
1082013
Bloodstream infections in patients with hematological malignancies: which is more fatal–cancer or resistant pathogens?
H Gedik, F Şimşek, A Kantürk, T Yildirmak, D Arica, D Aydin, N Demirel, ...
Therapeutics and clinical risk management, 743-752, 2014
882014
Colistin against colistin-only-susceptible Acinetobacter baumannii-related infections: monotherapy or combination therapy?
F Şimşek, H Gedik, MT Yıldırmak, NE Iris, A Türkmen, A Ersoy, M Ersöz, ...
Indian journal of medical microbiology 30 (4), 448-452, 2012
512012
Etiological causes of pancytopenia: A report of 137 cases
O Yokus, H Gedik
Avicenna journal of medicine 6 (04), 109-112, 2016
332016
The cost analysis of inpatients with COVID-19
H Gedik
Acta Medica Mediterr 36 (1), 3289-3292, 2020
272020
Vancomycin-resistant enterococci colonization and bacteremia in patients with hematological malignancies
H Gedik, T Yıldırmak, F Şimşek, A Kantürk, D Arıca, D Aydın, O Yokuş, ...
The Journal of Infection in Developing Countries 8 (09), 1113-1118, 2014
222014
Pulmonary involvement of Brucellosis: a report of six cases
F Simsek, MT Yildirmak, H Gedik, A Kantürk, EN Iris
African Health Sciences 11, 112-116, 2011
172011
Extended-Spectrum β-Lactamase Production Rates of Klebsiella spp. and Escherichia coli Strains Isolated From Infections and Fecal Samples of Healthy People
H Gedik, M Yahyaoglu, G Yörük, M Fincanc
Infectious Diseases in Clinical Practice 18 (2), 104-106, 2010
152010
Which multidrug-resitant bacteria are emerging in patients with hematological malignancies?: one-Year Report
H Gedik, F Şimşek, T Yıldırmak, A Kantürk, D Aydın, N Demirel, O Yokuş, ...
Indian Journal of Hematology and Blood Transfusion 31, 51-56, 2015
142015
The outcome of non-carbapenem-based empirical antibacterial therapy and VRE colonisation in patients with hematological malignancies
DN Gedik H, Yildirmak T, Simsek F, Kanturk A, Aydın D
African Health Sciences, 362-368, 2013
142013
Antibiotic resistance status and its costs in hematological patients: A two-year analysis
H Gedik
Caspian journal of internal medicine 8 (4), 276, 2017
132017
Vancomycin-resistant enterococci colonization in patients with hematological malignancies: screening and its cost-effectiveness
G Habip, K Arzu, Y Taner, A Deniz, A Demet, Y Osman, D Naciye, ...
African health sciences 14 (4), 899-905, 2014
132014
The expenditures related to the use of antifungal drugs in patients with hematological cancers: a cost analysis
H Gedik
ClinicoEconomics and Outcomes Research, 537-543, 2015
112015
Community-acquired intracranial suppurative infections: a 15-year report
T Yıldırmak, H Gedik, F Şimşek, A Kantürk
Surgical Neurology International 5, 2014
112014
Tuberculous meningitis: a report of 60 adult cases.
M Ersöz, MT Yildirmak, H Gedik, F Şimşek, A Kantürk, NE Iris, E Dinç
West indian medical journal 61 (6), 2012
112012
Risk factors for bloodstream infections due to extended-spectrum β-lactamase producing Enterobacteriaceae in cancer patients
S Çeken, G Iskender, H Gedik, F Duygu, D Mert, AH Kaya, F Altuntas, ...
The Journal of Infection in Developing Countries 12 (04), 265-272, 2018
102018
Primary or secondary antifungal prophylaxis in patients with hematological maligancies: efficacy and damage
H Gedik, F Şimşek, T Yıldırmak, A Kantürk, D Arıca, D Aydın, N Demirel, ...
Therapeutics and clinical risk management, 305-312, 2014
102014
Evaluation of risk factors for mortality in febrile neutropenia
S Çeken, H Gedik, G Iskender, M Demirelli, D Mert, GY Toros, ...
The Journal of Infection in Developing Countries 14 (08), 886-892, 2020
72020
Could neutrophil CD64 expression be used as a diagnostic parameter of bacteremia in patients with febrile neutropenia?
NE Iris, T Yıldırmak, H Gedik, F Şimşek, D Aydın, N Demirel, O Yokuş
Turkish Journal of Hematology 34 (2), 167, 2017
72017
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20